Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

FDA approves Descovy for HIV-1 PrEP

Oct. 4, 2019

Chinese researchers describe new HIV antivirals

Oct. 1, 2019

European Commission approves Trogarzo for HIV-1

Sep. 27, 2019

GlaxoSmithKline and ViiV Healthcare patent new compounds for HIV

Sep. 27, 2019

Thai vaccine works better in South Africa

Sep. 27, 2019

FDA approves Pifeltro and Delstrigo for virologically suppressed adults with HIV-1 infection

Sep. 23, 2019

Orion Biotechnology obtains Polish clearance to begin phase I study of microbicide gel

Sep. 13, 2019

Gilead discloses new HIV replication inhibitors

Sep. 12, 2019

Parasite protects T cells from HIV

Sep. 10, 2019

Merck & Co. describes HIV integrase inhibitors

Sep. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...